OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 146 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $151,000 | +7.1% | 71,520 | +151.8% | 0.01% | +40.0% |
| Q2 2015 | $141,000 | -56.1% | 28,401 | -30.8% | 0.01% | -54.5% |
| Q1 2015 | $321,000 | +61.3% | 41,046 | +25.0% | 0.01% | +57.1% |
| Q4 2014 | $199,000 | +8.2% | 32,826 | -24.1% | 0.01% | +16.7% |
| Q3 2014 | $184,000 | +37.3% | 43,229 | +98.7% | 0.01% | +50.0% |
| Q2 2014 | $134,000 | -40.4% | 21,761 | -37.2% | 0.00% | -33.3% |
| Q1 2014 | $225,000 | +64.2% | 34,640 | +42.6% | 0.01% | +50.0% |
| Q4 2013 | $137,000 | -78.8% | 24,297 | -76.9% | 0.00% | -78.9% |
| Q3 2013 | $645,000 | +119.4% | 105,247 | +109.0% | 0.02% | +90.0% |
| Q2 2013 | $294,000 | – | 50,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |